Verified JourneyMeds Customer Excellent provider
Testes: GLP-1 reduces inflammation, indicating possible fertility benefits
Ambetter does not cover Ozempic for: Weight loss in patients without diabetes Obesity management Prediabetes (A1C 5.7% to 6.4%) Cardiovascular risk reduction in non-diabetic patients Off-label metabolic syndrome treatment This is consistent across all 27 states where Ambetter operates marketplace plans
If side effects are partly peak-driven, a higher abdominal peak could plausibly trigger more early GI symptoms even when total exposure is similar
The next step is for Eli Lilly to submit a New Drug Application to the FDA, a review process that typically takes about a year, which puts realistic approval in 2027 at the earliest. Who might benefit from retatrutide
Gastrointestinal side effects are most common during the dose-escalation phase, when youre first starting tirzepatide or gradually increasing your dose